Showing results (31-40 of 84) with videos related to
Sort By:
Pageof 9
The Bone & Joint Journal|May 29, 2016
Nails or plates for fracture of the distal femur? data from the Victoria Orthopaedic Trauma Outcomes RegistryW Hoskins, R Sheehy, E R Edwards, et al.Lancet (London, England)|January 17, 1976
Influenza at Christ's Hospital: March, 1974T W Hoskins, J R Davies, A J Smith, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1988
Phase I trial of concurrent intraperitoneal and continuous intravenous infusion of fluorouracil in patients with refractory cancerB Reichman, M Markman, T Hakes, et al.Plos Computational Biology|November 18, 2021
Inferred expression regulator activities suggest genes mediating cardiometabolic genetic signalsJason W Hoskins, Charles C Chung, Aidan O'Brien, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1991
Persistent hypomagnesemia following cisplatin chemotherapy in patients with ovarian cancerM Markmann, R Rothman, B Reichman, et al.Gynecologic Oncology|June 11, 1991
Late effects of cisplatin-based chemotherapy on renal function in patients with ovarian carcinomaM Markman, R Rothman, T Hakes, et al.Gynecologic Oncology|November 11, 1991
Phase II trial of high-dose cisplatin with sodium thiosulfate nephroprotection in patients with advanced carcinoma of the uterine cervix previously untreated with chemotherapyB Reichman, M Markman, T Hakes, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 1992
Ifosfamide and mesna in previously treated advanced epithelial ovarian cancer: activity in platinum-resistant diseaseM Markman, T Hakes, B Reichman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
Phase II trial of intraperitoneal mitoxantrone in the management of refractory ovarian cancerM Markman, M George, T Hakes, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 1991
Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatinM Markman, R Rothman, T Hakes, et al.Pageof 9